Attached files

file filename
EX-99.1 - Q2 2017 EARNINGS RELEASE - Sabra Health Care REIT, Inc.sbraex9912017q2.htm
8-K - 8-K - Sabra Health Care REIT, Inc.sbra8-k2017q2.htm




q217cover.jpg



Disclaimer
Certain statements in this supplement contain “forward-looking” information as that term is defined by the Private Securities Litigation Reform Act of 1995. Any statements that do not relate to historical or current facts or matters are forward-looking statements. Examples of forward-looking statements include all statements regarding our proposed merger transaction with Care Capital Properties, Inc. (“CCP”), expected future financial position, results of operations, cash flows, liquidity, business strategy, growth opportunities, potential investments, and plans and objectives for future operations. You can identify some of the forward-looking statements by the use of forward-looking words such as “anticipate,” “believe,” “plan,” “estimate,” “expect,” “intend,” “should,” “may” and other similar expressions, although not all forward-looking statements contain these identifying words.
Our actual results may differ materially from those projected or contemplated by our forward-looking statements as a result of various factors, including among others, the following: our dependence on Genesis Healthcare, Inc. (“Genesis”) and certain wholly owned subsidiaries of Holiday AL Holdings LP until we are able to further diversify our portfolio; our dependence on the operating success of our tenants; the significant amount of and our ability to service our indebtedness; covenants in our debt agreements that may restrict our ability to pay dividends, make investments, incur additional indebtedness and refinance indebtedness on favorable terms; increases in market interest rates; changes in foreign currency exchange rates; our ability to raise capital through equity and debt financings; the impact of required regulatory approvals of transfers of healthcare properties; the effect of changing healthcare regulation and enforcement on our tenants and the dependence of our tenants on reimbursement from governmental and other third-party payors; the relatively illiquid nature of real estate investments; competitive conditions in our industry; the loss of key management personnel or other employees; the impact of litigation and rising insurance costs on the business of our tenants; the effect of our tenants declaring bankruptcy or becoming insolvent; uninsured or underinsured losses affecting our properties and the possibility of environmental compliance costs and liabilities; the ownership limits and anti-takeover defenses in our governing documents and Maryland law, which may restrict change of control or business combination opportunities; the impact of a failure or security breach of information technology in our operations; our ability to find replacement tenants and the impact of unforeseen costs in acquiring new properties; our ability to maintain our status as a real estate investment trust (“REIT”); changes in tax laws and regulations affecting REITs; and compliance with REIT requirements and certain tax and tax regulatory matters related to our status as a REIT. There are also risks that are inherent in the nature of the transaction with CCP, including the possibility that the parties may be unable to obtain required stockholder approvals or regulatory approvals or that other conditions to closing the transaction may not be satisfied, such that the transaction will not close or that the closing may be delayed; the potential adverse effect on tenant and vendor relationships, operating results and business generally resulting from the proposed transaction; the proposed transaction will require significant time, attention and resources, potentially diverting attention from the conduct of our business; the amount of debt that will need to be refinanced or amended in connection with the proposed merger and the ability to do so on acceptable terms; changes in healthcare regulation and political or economic conditions; the anticipated benefits of the proposed transaction may not be realized; the anticipated and unanticipated costs, fees, expenses and liabilities related to the transaction; the outcome of any legal proceedings related to the transaction; and the occurrence of any event, change or other circumstances that could give rise to the termination of the merger agreement. 
Additional information concerning risks and uncertainties that could affect our business can be found in our filings with the Securities and Exchange Commission (the “SEC”), including Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2016 and Item 1A of our Quarterly Report on Form 10-Q for the quarter ended June 30, 2017. Additional information concerning risks and uncertainties that could affect CCP’s business can be found in CCP’s filings with the SEC, including Item 1A of its Annual Report on Form 10-K for the year ended December 31, 2016. We do not intend, and we undertake no obligation, to update any forward-looking information to reflect events or circumstances after the date of this supplement or to reflect the occurrence of unanticipated events, unless required by law to do so.
Note Regarding Non-GAAP Financial Measures
This supplement includes the following financial measures defined as non-GAAP financial measures by the SEC: net operating income (“NOI”), Cash NOI, funds from operations attributable to common stockholders (“FFO”), Normalized FFO, Adjusted FFO (“AFFO”), Normalized AFFO, FFO per diluted common share, Normalized FFO per diluted common share, AFFO per diluted common share and Normalized AFFO per diluted common share. These measures may be different than non-GAAP financial measures used by other companies, and the presentation of these measures is not intended to be considered in isolation or as a substitute for financial information prepared and presented in accordance with U.S. generally accepted accounting principles. An explanation of these non-GAAP financial measures is included under “Reporting Definitions” in this supplement and reconciliations of these non-GAAP financial measures to the GAAP financial measures we consider most




comparable are included under “Reconciliations of NOI and Cash NOI" and "Reconciliations of FFO, Normalized FFO, AFFO and Normalized AFFO” in this supplement.
Tenant and Borrower Information
This supplement includes information regarding certain of our tenants that lease properties from us and our borrowers, most of which are not subject to SEC reporting requirements. This release also includes certain information regarding tenants who lease properties from CCP and their borrowers, most of which are also not subject to SEC reporting requirements. Genesis is subject to the reporting requirements of the SEC and is required to file with the SEC annual reports containing audited financial information and quarterly reports containing unaudited financial information. The information related to our tenants and borrowers that is provided in this supplement has been provided by, or derived solely from information provided by, such tenants and borrowers; and the information related to CCP’s tenants and borrowers that is provided in this release has been provided by CCP based on information it has obtained from its tenants and borrowers. We have not independently verified this information. We have no reason to believe that such information is inaccurate in any material respect. We are providing this data for informational purposes only. Genesis's filings with the SEC can be found at www.sec.gov.






Table of Contents

 
 
 





Company Information
Board of Directors
 
 
 
 
 
Richard K. Matros
Chairman of the Board, President and
Chief Executive Officer
Sabra Health Care REIT, Inc.
  
Michael J. Foster
Managing Director
RFE Management Corp.
 
 
Milton J. Walters
President
Tri-River Capital
  
Robert A. Ettl
Chief Operating Officer
Harvard Management Company
 
 
Craig A. Barbarosh
Partner
Katten Muchin Rosenman LLP
  
 
Senior Management
 
 
 
 
 
Richard K. Matros
Chairman of the Board, President and
Chief Executive Officer
  
Harold W. Andrews, Jr.
Executive Vice President,
Chief Financial Officer and Secretary
 
 
Talya Nevo-Hacohen
Executive Vice President,
Chief Investment Officer and Treasurer
  
 
Other Information
 
 
 
 
 
Corporate Headquarters
18500 Von Karman Avenue, Suite 550
Irvine, CA 92612
  
Transfer Agent
American Stock Transfer and Trust Company
6201 15th Avenue
Brooklyn, NY 11219
www.sabrahealth.com

The information in this supplemental information package should be read in conjunction with the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other information filed with the SEC. The Reporting Definitions and Reconciliations of Non-GAAP Measures are an integral part of the information presented herein.

On Sabra's website, www.sabrahealth.com, you can access, free of charge, Sabra’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Sections 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, as soon as reasonably practicable after such material is filed with, or furnished to, the SEC. The information contained on Sabra’s website is not incorporated by reference into, and should not be considered a part of, this supplemental information package. All material filed with the SEC can also be accessed through its website, www.sec.gov.

For more information, contact Harold W. Andrews, Jr., Executive Vice President, Chief Financial Officer and Secretary at (949) 679-0243.

 

sabralogo33117.jpg
 
1


SABRA HEALTH CARE REIT, INC.
COMPANY FACT SHEET
Company Profile
Sabra Health Care REIT, Inc., a Maryland corporation (“Sabra,” the “Company” or “we”), operates as a self-administered, self-managed REIT that, through its subsidiaries, owns and invests in real estate serving the healthcare industry. Sabra primarily generates revenues by leasing properties to tenants and operators throughout the United States and Canada.
As of June 30, 2017, Sabra’s investment portfolio included 183 real estate properties held for investment (consisting of (i) 96 Skilled Nursing/Transitional Care facilities, (ii) 75 Senior Housing facilities, (iii) 11 Senior Housing facilities operated by third-party property managers pursuant to property management agreements (“Managed Properties”) and (iv) one Acute Care Hospital), eight investments in loans receivable (consisting of (i) four mortgage loans, (ii) two construction loans, (iii) one mezzanine loan, and (iv) one pre-development loan), and 12 preferred equity investments. As of June 30, 2017, Sabra’s real estate properties held for investment included 18,830 beds/units, spread across the United States and Canada.
Objectives and Strategies
Our objectives are to grow our investment portfolio while diversifying our portfolio by tenant, asset class and geography within the healthcare sector. We plan to achieve these objectives primarily through making investments directly or indirectly in healthcare real estate. We may also achieve our objective of diversifying our portfolio by tenant and asset class through select asset sales and other arrangements with Genesis and other tenants. We have entered into memoranda of understanding with Genesis to market for sale 35 skilled nursing facilities and we have made certain other lease and corporate guarantee amendments for the remaining 43 facilities leased to Genesis. Upon completion of the sales, these asset sales and amendments will have the benefit of reducing our net operating income concentration in Genesis and skilled nursing facilities, as well as strengthening our remaining Genesis-operated portfolio through the lease term extensions and guarantee enhancements; provided, however, that there can be no assurances that we will successfully complete these sales on the terms or timing contemplated by the memoranda of understanding, or at all, in which event we may not achieve the anticipated benefits from such sales. As of June 30, 2017, we completed the sale of one of these facilities and subsequent to June 30, 2017, we completed the sale of one additional facility. Marketing of the remaining 33 facilities is ongoing and is expected to be completed in the second half of 2017.
We expect to continue to grow our portfolio primarily through the acquisition of assisted living, independent living and memory care facilities in the U.S. and Canada and through the acquisition of Skilled Nursing/Transitional Care facilities in the U.S. We have and will continue to opportunistically acquire other types of healthcare real estate, originate financing secured directly or indirectly by healthcare facilities and invest in the development of Senior Housing and Skilled Nursing/Transitional Care facilities. We also expect to expand our portfolio through the development of purpose-built healthcare facilities through pipeline agreements and other arrangements with select developers. We further expect to work with existing operators to identify strategic development opportunities. These opportunities may involve replacing or renovating facilities in our portfolio that may have become less competitive and new development opportunities that present attractive risk-adjusted returns. In addition to pursuing acquisitions with triple-net leases, we expect to continue to pursue other forms of investment, including investments in Managed Properties, mezzanine and secured debt investments, and joint ventures for Senior Housing and Skilled Nursing/Transitional Care facilities.
In general, we originate loans and make preferred equity investments when an attractive investment opportunity is presented and either (a) the property is in or near the development phase or (b) the development of the property is completed but the operations of the facility are not yet stabilized. A key component of our strategy related to loan originations and preferred equity investments is our having the option to purchase the underlying real estate that is owned by our borrowers (and that directly or indirectly secures our loan investment) or by the entity in which we have an investment. These options become exercisable upon the occurrence of various criteria, such as the passage of time or the achievement of certain operating goals, and the method to determine the purchase price upon exercise of the option is set in advance based on the same valuation methods we use to value our investments in healthcare real estate. This strategy allows us to diversify our revenue streams and build relationships with operators and developers, and provides us with the option to add new properties to our existing real estate portfolio if we determine that those properties enhance our investment portfolio and stockholder value at the time the options are exercisable.

 
 

SABRA HEALTH CARE REIT, INC.
COMPANY FACT SHEET (CONTINUED)
As of June 30, 2017

Market Facts
 
Credit Ratings
Common Stock Information
 
 
Closing Price
$24.10
 
Moody's
 
52-Week range
$19.30 - $29.10
 
  Corporate Rating
Ba3 (review for upgrade)
Common Equity Market Capitalization:
$1.6 billion
 
  Unsecured Notes Rating
Ba3 (review for upgrade)
Outstanding Shares
65.4 million
 
  Preferred Equity Rating
B2 (review for upgrade)
Enterprise Value:
$2.9 billion
 
S&P
 
 
 
 
Corporate Rating
BB- (CreditWatch positive)
Ticker symbols:
 
 
Unsecured Notes/Unsecured Credit Facility
BB (CreditWatch positive)
Common Stock
SBRA
 
Preferred Equity Rating
B- (CreditWatch positive)
Preferred Stock
SBRAP
 
Fitch
 
Stock Exchange:
NASDAQ
 
Corporate Rating
BB+ (Rating Watch Positive)
Governance
 
Unsecured Notes/Unsecured Credit Facility
BB+ (Rating Watch Positive)
(As of July 1, 2017)
 
Preferred Equity Rating
BB- (Rating Watch Positive)
ISS Governance QuickScore
4
 
 
 

Portfolio Information
Investment in Real Estate Properties
 
 
Real Estate Property Bed/Unit Count
 
Skilled Nursing/Transitional Care
96

 
Skilled Nursing/Transitional Care
10,689

Senior Housing
75

 
Senior Housing
7,070

Managed Properties
11

 
Managed Properties
1,001

Acute Care Hospital
1

 
Acute Care Hospital
70

Total Equity Investments
183

 
Total Beds/Units
18,830

 
 
 
 
 
Investments in Loans Receivable (1)
8

 
Countries
2

Preferred Equity Investments (2)
12

 
U.S. States
37

Total Investments
203

 
Relationships
34


(1) Our investments in Loans Receivable include investments secured directly or indirectly by one Skilled Nursing/Transitional Care facility with 141 beds/units, six Senior Housing developments with 409 beds/units, and land for one future Senior Housing development.
(2) Our Preferred Equity Investments include investments in entities owning 11 Senior Housing developments with 1,162 beds/units and one Skilled Nursing/Transitional Care facility with 140 beds/units.

sabralogo08.jpg
See reporting definitions.
2





SABRA HEALTH CARE REIT, INC.
FINANCIAL HIGHLIGHTS
(dollars in thousands, except per share data)
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2017
 
2016
 
2017
 
2016
Revenues
$
64,736

 
$
74,249

 
$
127,386

 
$
136,808

Net operating income
60,329

 
72,809

 
120,559

 
133,956

Net income attributable to common stockholders
17,960

 
34,915

 
34,222

 
16,643

FFO attributable to common stockholders
31,148

 
51,372

 
66,547

 
85,279

Normalized FFO attributable to common stockholders
36,407

 
39,763

 
72,768

 
81,133

AFFO attributable to common stockholders
36,134

 
49,423

 
72,321

 
84,248

Normalized AFFO attributable to common stockholders
35,244

 
38,354

 
70,457

 
77,686

Per common share data attributable to common stockholders:
 
 
 
 
 
 
 
Diluted EPS
$
0.27

 
$
0.53

 
$
0.52

 
$
0.25

Diluted FFO
0.47

 
0.78

 
1.01

 
1.30

Diluted Normalized FFO
0.55

 
0.61

 
1.11

 
1.24

Diluted AFFO
0.55

 
0.75

 
1.10

 
1.28

Diluted Normalized AFFO
0.53

 
0.58

 
1.07

 
1.18

 
 
 
 
 
 
 
 
Net cash flow from operations
$
22,433

 
$
69,768

 
$
53,871

 
$
94,494

 
 
 
 
 
 
 
 
Investment Portfolio
June 30, 2017
 
December 31, 2016
 
 
 
 
Real Estate Properties held for investment (1)
183

 
183

 
 
 
 
Real Estate Properties held for investment, gross ($)
$
2,309,596

 
$
2,292,345

 
 
 
 
Total Beds/Units
18,830

 
18,878

 
 
 
 
Weighted Average Remaining Lease Term (in months)
112

 
112

 
 
 
 
Total Investments in Loans Receivable (#)
8

 
10

 
 
 
 
Total Investments in Loans Receivable, gross ($) (2)
$
49,635

 
$
51,432

 
 
 
 
Total Preferred Equity Investments (#)
12

 
12

 
 
 
 
Total Preferred Equity Investments, gross ($)
$
45,345

 
$
45,190

 
 
 
 
Debt
June 30, 2017
 
December 31, 2016
 
 
 
 
Principal Balance
 
 
 
 
 
 
 
Fixed Rate Debt
$
862,195

 
$
863,638

 
 
 
 
Variable Rate Debt - Swapped (3)
341,287

 
338,000

 
 
 
 
Variable Rate Debt - Floating
32,000

 
26,000

 
 
 
 
Total Debt
1,235,482

 
1,227,638

 
 
 
 
 
 
 
 
 
 
 
 
Cash
(13,235
)
 
(25,663
)
 
 
 
 
Net Debt (4)
$
1,222,247

 
$
1,201,975

 
 
 
 
 
 
 
 
 
 
 
 
Weighted Average Effective Interest Rate
 
 
 
 
 
 
 
Fixed Rate Debt
5.16
%
 
5.16
%
 
 
 
 
Variable Rate Debt - Swapped (3)
2.99
%
 
2.99
%
 
 
 
 
Variable Rate Debt - Floating
3.22
%
 
2.77
%
 
 
 
 
Total Debt
4.51
%
 
4.51
%
 
 
 
 
 
 
 
 
 
 
 
 
% of Total
 
 
 
 
 
 
 
Fixed Rate Debt
69.8
%
 
70.3
%
 
 
 
 
Variable Rate Debt - Swapped (3)
27.6
%
 
27.5
%
 
 
 
 
Variable Rate Debt - Floating
2.6
%
 
2.2
%
 
 
 
 
 
 
 
 
 
 
 
 
Availability Under Revolving Credit Facility
$
468,000

 
$
474,000

 
 
 
 
Available Liquidity (5)
$
480,989

 
$
499,547

 
 
 
 
 
(1) Real Estate Properties held for investment include Managed Properties.
(2) Total Investments in Loans Receivable consists of principal plus capitalized origination fees net of loan loss reserves.
(3) As of June 30, 2017, variable rate debt - swapped includes $245.0 million subject to swap agreements that fix LIBOR at 0.90%, $69.3 million (CAD $90.0 million) and $27.0 million (CAD $35.0 million) subject to swap agreements that fix the Canadian Offer Dollar Rate (“CDOR”) at 1.59% and 0.93%, respectively.
(4) Net Debt excludes deferred financing costs and discounts.
(5) Available liquidity represents unrestricted cash, excluding cash associated with a consolidated joint venture, and availability under the revolving credit facility.

sabralogo08.jpg
See reporting definitions.
3





SABRA HEALTH CARE REIT, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(dollars in thousands, except per share data)
 

 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2017
 
2016
 
2017
 
2016
Revenues:
 
 
 
 
 
 
 
Rental income
$
55,904

 
$
55,297

 
$
113,128

 
$
110,609

Interest and other income
2,027

 
16,993

 
3,972

 
22,325

Resident fees and services
6,805

 
1,959

 
10,286

 
3,874

 
 
 
 
 
 
 
 
Total revenues
64,736

 
74,249

 
127,386

 
136,808

 
 
 
 
 
 
 
 
Expenses:
 
 
 
 
 
 
 
Depreciation and amortization
17,220

 
16,405

 
36,357

 
34,171

Interest
15,862

 
16,427

 
31,650

 
33,345

Operating expenses
4,407

 
1,440

 
6,827

 
2,852

General and administrative
11,149

 
4,636

 
18,022

 
9,350

Provision for doubtful accounts and loan losses
535

 
223

 
2,305

 
2,746

Impairment of real estate

 

 

 
29,811

 
 
 
 
 
 
 
 
Total expenses
49,173

 
39,131

 
95,161

 
112,275

 
 
 
 
 
 
 
 
Other income (expense):
 
 
 
 
 
 
 
Loss on extinguishment of debt

 

 

 
(556
)
Other income
941

 
2,400

 
3,070

 
2,400

Net gain (loss) on sale of real estate
4,032

 
(52
)
 
4,032

 
(4,654
)
 
 
 
 
 
 
 
 
Total other income (expense)
4,973

 
2,348

 
7,102

 
(2,810
)
 
 
 
 
 
 
 
 
Net income
20,536

 
37,466

 
39,327

 
21,723

 
 
 
 
 
 
 
 
Net (income) loss attributable to noncontrolling interests
(16
)
 
9

 
16

 
41

 
 
 
 
 
 
 
 
Net income attributable to Sabra Health Care REIT, Inc.
20,520

 
37,475

 
39,343

 
21,764

 
 
 
 
 
 
 
 
Preferred stock dividends
(2,560
)
 
(2,560
)
 
(5,121
)
 
(5,121
)
 
 
 
 
 
 
 
 
Net income attributable to common stockholders
$
17,960

 
$
34,915

 
$
34,222

 
$
16,643

 
 
 
 
 
 
 
 
Net income attributable to common stockholders, per:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic common share
$
0.27

 
$
0.53

 
$
0.52

 
$
0.25

 
 
 
 
 
 
 
 
Diluted common share
$
0.27

 
$
0.53

 
$
0.52

 
$
0.25

 
 
 
 
 
 
 
 
Weighted-average number of common shares outstanding, basic
65,438,739

 
65,303,057

 
65,396,146

 
65,274,845

 
 
 
 
 
 
 
 
Weighted-average number of common shares outstanding, diluted
65,670,853

 
65,503,383

 
65,694,019

 
65,454,337

 
 
 
 
 
 
 
 


sabralogo08.jpg
See reporting definitions.
4





SABRA HEALTH CARE REIT, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(dollars in thousands, except per share data)
 

 
June 30, 2017
 
December 31, 2016
 
(unaudited)
 
 
Assets
 
 
 
Real estate investments, net of accumulated depreciation of $314,103 and $282,812 as of June 30, 2017 and December 31, 2016, respectively
$
1,995,911

 
$
2,009,939

Loans receivable and other investments, net
94,208

 
96,036

Cash and cash equivalents
13,235

 
25,663

Restricted cash
9,413

 
9,002

Prepaid expenses, deferred financing costs and other assets, net
141,193

 
125,279

Total assets
$
2,253,960

 
$
2,265,919

 
 
 
 
Liabilities
 
 
 
Mortgage notes, net
$
159,366

 
$
160,752

Revolving credit facility
32,000

 
26,000

Term loans, net
339,248

 
335,673

Senior unsecured notes, net
689,508

 
688,246

Accounts payable and accrued liabilities
37,123

 
39,639

Total liabilities
1,257,245

 
1,250,310

 
 
 
 
Equity
 
 
 
Preferred stock, $.01 par value; 10,000,000 shares authorized, 5,750,000 shares issued and outstanding as of June 30, 2017 and December 31, 2016
58

 
58

Common stock, $.01 par value; 125,000,000 shares authorized, 65,425,434 and 65,285,614 shares issued and outstanding as of June 30, 2017 and December 31, 2016, respectively
654

 
653

Additional paid-in capital
1,210,895

 
1,208,862

Cumulative distributions in excess of net income
(214,078
)
 
(192,201
)
Accumulated other comprehensive loss
(833
)
 
(1,798
)
Total Sabra Health Care REIT, Inc. stockholders’ equity
996,696

 
1,015,574

Noncontrolling interests
19

 
35

Total equity
996,715

 
1,015,609

Total liabilities and equity
$
2,253,960

 
$
2,265,919






sabralogo08.jpg
See reporting definitions.
5





SABRA HEALTH CARE REIT, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
 
Six Months Ended June 30,

2017
 
2016
Cash flows from operating activities:

 

Net income
$
39,327

 
$
21,723

Adjustments to reconcile net income to net cash provided by operating activities:

 

Depreciation and amortization
36,357

 
34,171

Non-cash interest income adjustments
51

 
443

Amortization of deferred financing costs
2,558

 
2,494

Stock-based compensation expense
4,319

 
3,652

Amortization of debt discount
57

 
54

Loss on extinguishment of debt

 
556

Straight-line rental income adjustments
(9,578
)
 
(11,117
)
Provision for doubtful accounts and loan losses
2,305

 
2,746

Change in fair value of contingent consideration
(822
)
 
(50
)
Net (gain) loss on sales of real estate
(4,032
)
 
4,654

Impairment of real estate

 
29,811

Changes in operating assets and liabilities:


 


Prepaid expenses and other assets
(15,129
)
 
3,265

Accounts payable and accrued liabilities
327

 
4,324

Restricted cash
(1,869
)
 
(2,232
)

 
 
 
Net cash provided by operating activities
53,871

 
94,494

Cash flows from investing activities:

 

Acquisition of real estate
(14,456
)
 

Origination and fundings of loans receivable
(927
)
 
(6,283
)
Origination and fundings of preferred equity investments
(76
)
 
(6,172
)
Additions to real estate
(1,294
)
 
(874
)
Repayment of loans receivable
1,547

 
193,893

Repayments of preferred equity investments
2,766

 

Net proceeds from the sales of real estate
6,099

 
75,456


 
 

Net cash (used in) provided by investing activities
(6,341
)
 
256,020

Cash flows from financing activities:

 

Net borrowing (repayments) of revolving credit facility
6,000

 
(255,000
)
Proceeds from term loans

 
69,360

Principal payments on mortgage notes
(2,049
)
 
(2,060
)
Payments of deferred financing costs
(124
)
 
(5,931
)
Issuance of common stock, net
(3,224
)
 
(1,289
)
Dividends paid on common and preferred stock
(60,691
)
 
(59,288
)

 
 
 
Net cash used in financing activities
(60,088
)
 
(254,208
)

 
 

Net (decrease) increase in cash and cash equivalents
(12,558
)
 
96,306

Effect of foreign currency translation on cash and cash equivalents
130

 
128

Cash and cash equivalents, beginning of period
25,663

 
7,434


 
 

Cash and cash equivalents, end of period
$
13,235

 
$
103,868

Supplemental disclosure of cash flow information:
 
 
 
Interest paid
$
28,944

 
$
30,581


sabralogo08.jpg
See reporting definitions.
6




SABRA HEALTH CARE REIT, INC.
CAPITALIZATION
(dollars in thousands, except per share data)
Debt
June 30, 2017
 
December 31, 2016
Mortgage notes
$
162,195

 
$
163,638

Revolving credit facility
32,000

 
26,000

Term loans
341,287

 
338,000

Senior unsecured notes
700,000

 
700,000

 
 
 
 
Total Principal Balance
1,235,482

 
1,227,638

Deferred financing costs and discounts
(15,360
)
 
(16,967
)
Total Debt, net
$
1,220,122

 
$
1,210,671

 

Revolving Credit Facility
June 30, 2017
 
December 31, 2016
Credit facility availability
$
468,000

 
$
474,000

Credit facility capacity
500,000

 
500,000


Enterprise Value
 
 
 
 
 
As of June 30, 2017
Shares Outstanding
 
Price
 
Value
Common stock
65,425,434

 
$
24.10

 
$
1,576,753

Preferred stock
5,750,000

 
25.59

 
147,143

Total debt
 
 
 
 
1,235,482

Cash and cash equivalents
 
 
 
 
(13,235
)
 
 
 
 
 
 
Total Enterprise Value
 
 
 
 
$
2,946,143

 
 
 
 
 
 
As of December 31, 2016
Shares Outstanding
 
Price
 
Value
Common stock
65,285,614

 
$
24.42

 
$
1,594,275

Preferred stock
5,750,000

 
25.15

 
144,613

Total debt
 
 
 
 
1,227,638

Cash and cash equivalents
 
 
 
 
(25,663
)
 
 
 
 
 
 
Total Enterprise Value
 
 
 
 
$
2,940,863

 
 
 
 
 
 
 

Common Stock and Equivalents
Weighted Average Common Shares
 
Three Months Ended June 30, 2017
 
Six Months Ended June 30, 2017
EPS, FFO and Normalized FFO
 
AFFO and Normalized AFFO
 
EPS, FFO and Normalized FFO
 
EPS, AFFO and Normalized AFFO
Common stock
65,412,425

 
65,412,425

 
65,370,524

 
65,370,524

Common equivalents
26,314

 
26,314

 
25,622

 
25,622

 
 
 
 
 
 
 
 
Basic common and common equivalents
65,438,739

 
65,438,739

 
65,396,146

 
65,396,146

Dilutive securities:
 
 
 
 
 
 
 
Restricted stock and units
232,114

 
547,201

 
297,873

 
612,956

 
 
 
 
 
 
 
 
Diluted common and common equivalents
65,670,853

 
65,985,940

 
65,694,019

 
66,009,102

 
 
 
 
 
 
 
 



sabralogo08.jpg
See reporting definitions.
7




SABRA HEALTH CARE REIT, INC.
INDEBTEDNESS
June 30, 2017
(dollars in thousands)
 
Principal
 
Weighted Average
Effective Rate (1)
 
% of Total
Fixed Rate Debt
 
 
 
 
 
Secured mortgage debt 
$
162,195

  
3.87
%
 
13.1
%
Unsecured senior notes  
700,000

  
5.46
%
 
56.7
%
 
 
 
 
 
 
Total fixed rate debt
862,195

  
5.16
%
 
69.8
%
Variable Rate Debt
 
 
 
 
 
Revolving credit facility (2)
32,000

  
3.22
%
 
2.6
%
Term loans (2)
341,287

 
2.99
%
 
27.6
%
 
 
 
 
 
 
Total variable rate debt
373,287

  
3.01
%
 
30.2
%
 
 
 
 
 
 
Total Debt
$
1,235,482

  
4.51
%
 
100.0
%
Secured Debt
 
 
 
 
 
Secured mortgage debt
$
162,195

  
3.87
%
 
13.1
%
Unsecured Debt
 
 
 
 
 
Unsecured senior notes 
700,000

  
5.46
%
 
56.7
%
Revolving credit facility (2)
32,000

  
3.22
%
 
2.6
%
Term loans (2)
341,287

 
2.99
%
 
27.6
%
 
 
 
 
 
 
Total unsecured debt
1,073,287

  
4.61
%
 
86.9
%
 
 
 
 
 
 
Total Debt
$
1,235,482

  
4.51
%
 
100.0
%

(1) Weighted average effective interest rate includes private mortgage insurance and impact of interest rate swap agreements.
(2) Includes $245.0 million subject to swap agreements that fix LIBOR at 0.90%, $69.3 million (CAD $90.0 million) and $27.0 million (CAD $35.0 million) subject to swap agreements that fix CDOR at 1.59% and 0.93%, respectively. Excluding these amounts, variable rate debt was 2.6% of total debt as of June 30, 2017.
Maturities
Secured Mortgage Debt
 
Unsecured Senior Notes
 
Term Loans
  
Revolving Credit Facility (1)
 
Total
 
Principal
 
Rate (2)
 
Principal
 
Rate (2)
 
Principal
 
Rate (2)
  
Principal
 
Rate (2)
 
Principal
 
Rate (2)
7/1/17-12/31/17
$
2,090

 
3.45
%
 
$

 

  
$

 

  
$

 

 
$
2,090

 
3.45
%
2018
4,283

 
3.45
%
 

 

  

 

  

 

 
4,283

 
3.45
%
2019
4,426

 
3.45
%
 

 

  

 

  

 

 
4,426

 
3.45
%
2020
4,575

 
3.46
%
 

 

  

 

  
32,000

 
3.22
%
 
36,575

 
3.25
%
2021
19,941

 
3.46
%
 
500,000

 
5.50
%
  
341,287

 
3.07
%
  

 

 
861,228

 
4.49
%
2022
4,285

 
3.44
%
 

 

  

 

  

 

 
4,285

 
3.44
%
2023
4,427

 
3.45
%
 
200,000

 
5.38
%
 

 

  

 

 
204,427

 
5.34
%
2024
4,573

 
3.45
%
 

 

  

 

  

 

 
4,573

 
3.45
%
2025
4,725

 
3.46
%
 

 

  

 

  

 

 
4,725

 
3.46
%
2026
4,882

 
3.47
%
 

 

 

 

 

 

 
4,882

 
3.47
%
Thereafter
103,988

 
3.60
%
 

 

  

 

  

 

 
103,988

 
3.60
%
Total principal balance
162,195

 
 
 
700,000

 
 
 
341,287

 
 
  
32,000

 
 
 
1,235,482

 
 
Discount

 
 
 
(458
)
 
 
 

 
 
 

 
 
 
(458
)
 
 
Deferred financing costs
(2,829
)
 
 
 
(10,034
)
 
 
 
(2,039
)
 
 
 

 
 
 
(14,902
)
 
 
Total debt, net
$
159,366

 
 
 
$
689,508

 
 
 
$
339,248

 
 
  
$
32,000

 
 
 
$
1,220,122

 
 
Wtd. avg. maturity/years
23.9

 
 
 
4.3

 
 
 
3.5

 
 
  
2.5

 
 
 
6.6

 
 
Wtd. avg. effective interest rate(3)
3.87
%
 
 
 
5.46
%
 
 
 
2.99
%
 
 
  
3.22
%
 
 
 
4.51
%
 
 

(1) Revolving Credit Facility is subject to two six-month extension options.
(2) Represents actual contractual interest rates excluding private mortgage insurance and impact of interest rate swap agreements.
(3) Weighted average effective interest rate includes private mortgage insurance and impact of interest rate swap agreements.

sabralogo08.jpg
See reporting definitions.
8




SABRA HEALTH CARE REIT, INC.
KEY CREDIT STATISTICS (1) 

 
 
 
 
 
 
 
 
June 30, 2017
 
December 31, 2016
Net Debt to Adjusted EBITDA (2)
 
5.35x

 
5.22x

Interest Coverage
 
3.91x

 
4.00x

Fixed Charge Coverage Ratio
 
3.16x

 
3.20x

Total Debt/Asset Value
 
43
%
 
43
%
Secured Debt/Asset Value
 
6
%
 
6
%
Unencumbered Assets/Unsecured Debt
 
247
%
 
247
%
 
 
 
 
 
Cost of Permanent Debt (3)
 
4.55
%
 
4.55
%
 
 
 
 
 
Corporate Ratings (Moody's, S&P, Fitch)
 
Ba3 / BB- / BB+

 
Ba3 / BB- / BB+































(1) Key credit statistics are calculated in accordance with the credit agreement (excluding net debt to adjusted EBITDA) relating to the revolving credit facility and the indentures relating to our unsecured senior notes.
(2) Adjusted EBITDA is calculated as earnings before interest, taxes, depreciation and amortization ("EBITDA") excluding the impact of stock-based compensation expense under the Company's long-term equity award program, asset-specific loan loss reserves, and out of period reserves and is further adjusted to give effect to acquisitions and dispositions completed as of and subsequent to the date reported as though such acquisitions and dispositions occurred at the beginning of the period. Net Debt excludes deferred financing costs and discounts.
(3) Excludes revolving credit facility balance, if any, which had an interest rate of 3.22% and 2.77% as of June 30, 2017 and December 31, 2016, respectively.

sabralogo08.jpg
See reporting definitions.
9





SABRA HEALTH CARE REIT, INC.
PORTFOLIO SUMMARY
June 30, 2017
(dollars in thousands)
Total Property Portfolio
 
 
 
 
 
GAAP Rental Income (1)
 
Net Operating Income (1)
 
Number of
Beds/Units
 
 
Number of
Properties
 
 
 
Three Months Ended June 30,
 
Facility Type
 
 
Investment
 
2017
 
2016
 
2017
 
2016
 
Skilled Nursing/Transitional Care
 
96

 
$
1,038,958

 
$
34,598

 
$
34,156

 
$
34,598

 
$
34,156

 
10,689

Senior Housing
 
75

 
1,044,664

 
19,930

 
19,768

 
19,930

 
19,768

 
7,070

Managed Properties
 
11

 
164,334

 

 

 
2,398

 
519

 
1,001

Acute Care Hospital
 
1

 
61,640

 
1,376

 
1,373

 
1,376

 
1,373

 
70

Total 
 
183

 
$
2,309,596

 
$
55,904


$
55,297

 
$
58,302

 
$
55,816

 
18,830

Same Store Property Portfolio (2)

 
 
 
Cash Rent
 
Cash Net Operating Income
 
 
 
 
Three Months Ended June 30,
Facility Type
 
Number of
Properties
 
2017
 
2016
 
2017
 
2016
Skilled Nursing/Transitional Care
 
85

 
$
31,149

 
$
30,238

 
$
31,149

 
$
30,238

Senior Housing
 
61

 
15,431

 
15,580

 
15,431

 
15,580

Managed Properties
 
2

 

 

 
563

 
519

Acute Care Hospital
 
1

 
1,281

 
1,256

 
1,281

 
1,256

Total
 
149

 
$
47,861

 
$
47,074

 
$
48,424

 
$
47,593

Tenant Facility Statistics (3)

 
Coverage
 
 
 
 
 
 
 
 
 
 
EBITDAR
 
EBITDARM
 
Occupancy Percentage
 
Skilled Mix
 
 
Twelve Months Ended June 30,
Facility Type
 
2017
 
2016
 
2017
 
2016
 
2017
 
2016
 
2017
 
2016
Skilled Nursing/Transitional Care
 
1.56x
 
1.45x
 
1.86x
 
1.75x
 
88.4
%
 
86.9
%
 
43.1
%
 
41.4
%
Senior Housing
 
1.16x
 
1.17x
 
1.34x
 
1.34x
 
88.3
%
 
89.7
%
 
NA

 
NA

Managed Properties
 
NA
 
NA
 
NA
 
NA
 
89.7
%
 
75.3
%
 
NA

 
NA

 
 
Twelve Months Ended June 30,
Fixed Charge Coverage Ratio (4)
 
2017
 
2016
Genesis Healthcare, Inc.
 
1.18x
 
1.27x
Tenet Health Care Corporation
 
2.04x
 
2.18x
Holiday AL Holdings LP
 
1.13x
 
1.18x
Same Store Tenant Facility Statistics (5)

 
Coverage
 
 
 
 
 
 
 
 
 
 
EBITDAR
 
EBITDARM
 
Occupancy Percentage
 
Skilled Mix
 
 
Twelve Months Ended June 30,
Facility Type
 
2017
 
2016
 
2017
 
2016
 
2017
 
2016
 
2017
 
2016
Skilled Nursing/Transitional Care
 
1.33x
 
1.31x
 
1.67x
 
1.64x
 
87.3
%
 
87.6
%
 
40.5
%
 
41.9
%
Senior Housing
 
1.33x
 
1.35x
 
1.52x
 
1.55x
 
88.9
%
 
90.2
%
 
NA

 
NA

Managed Properties
 
NA
 
NA
 
NA
 
NA
 
61.4
%
 
68.1
%
 
NA

 
NA


(1) GAAP Rental Income and Net Operating Income include $5.0 million and $5.5 million of straight-line rental income adjustments for the three months ended June 30, 2017 and 2016, respectively.
(2) Same store property portfolio includes all facilities owned for the full period in both comparison periods.
(3) Occupancy Percentage, Skilled Mix and EBITDARM/EBITDAR coverages (collectively, “Facility Statistics”) for each period presented include only Stabilized Facilities owned by the Company as of the end of the respective period. Facility Statistics are only included in periods subsequent to our acquisition. EBITDARM Coverage and EBITDAR Coverage exclude tenants with significant corporate guarantees. Facility Statistics are presented one quarter in arrears, except for Managed Properties which are presented as of the latest quarter.
(4) Fixed Charge Coverage Ratio is presented one quarter in arrears for tenants with significant corporate guarantees. See Reporting Definitions for definition of Fixed Charge Coverage Ratio.
(5) Same store Facility Statistics are presented for Stabilized Facilities owned for the full period in both comparison periods.

SABRA HEALTH CARE REIT, INC.
PORTFOLIO SUMMARY (CONTINUED)
PRO FORMA FOR CCP MERGER
June 30, 2017
(dollars in thousands)

Lease Coverage (1)

 
 
 
 
 
 
 
 
Twelve Months Ended June 30, 2017
Facility Type
 
Sabra
 
CCP
 
Combined
Skilled Nursing/Transitional Care
 
1.56x
 
1.19x
 
1.31x
Senior Housing
 
1.16x
 
0.92x
 
1.12x
Acute Care Hospital
 
NA
 
6.43x
 
6.43x
Tenants with Significant Corporate Guarantees (1)
 
 
 
 
 
 
Genesis Healthcare, Inc.
 
1.18x
 
NA
 
1.18x
Tenet Health Care Corporation
 
2.04x
 
NA
 
2.04x
Holiday AL Holdings LP
 
1.13x
 
NA
 
1.13x
CCP (4 Tenants)
 
NA
 
1.10x
 
1.10x
Pro Forma Top 10 Tenants (2)
 
 
 
 
 
 
 
 
 
Twelve Months Ended June 30, 2017
Facility Type
 
Number of Facilities (3)
 
Lease Coverage (1)
 
Annualized
Cash NOI (3)
 
% of Annualized Cash NOI
Genesis Healthcare, Inc.
 
77

 
1.18x
 
$
78,441

 
13.9
%
Senior Care Centers
 
38

 
1.08x
 
56,819

 
10.1
%
Signature Healthcare
 
49

 
0.91x
 
49,627

 
8.8
%
Avamere Family of Companies
 
29

 
1.35x
 
40,052

 
7.1
%
Holiday AL Holdings LP
 
21

 
1.13x
 
32,718

 
5.8
%
Signature Behavioral
 
6

 
1.57x
(4) 
30,288

 
5.4
%
NMS Healthcare
 
5

 
1.91x
 
25,362

 
4.5
%
Magnolia Health Systems
 
24

 
1.50x
 
15,608

 
2.8
%
The McGuire Group
 
7

 
1.91x
 
14,891

 
2.6
%
Wingate Healthcare
 
11

 
0.80x
 
14,253

 
2.5
%












(1) Lease Coverage is defined as the EBITDAR coverage for the facilities operated by the applicable tenant unless there is a corporate guaranty and the guarantor level fixed charge coverage is a more meaningful indicator of the tenants’ ability to make rent payments on stabilized facilities. Tenants with significant corporate guarantees represent 47.0% of the combined pro forma annualized Cash NOI. Lease Coverage is presented one quarter in arrears.
(2) Includes all acquisitions through June 30, 2017.
(3) Includes all stable, non-stable and held for sale facilities.
(4) Signature Behavioral was acquired subsequent to the Lease Coverage period presented. Accordingly, the coverage is presented here at the underwritten stabilized Lease Coverage level.

SABRA HEALTH CARE REIT, INC.
PORTFOLIO SUMMARY (CONTINUED)
June 30, 2017
(dollars in thousands)

Loans Receivable and Other Investments
Loan Type
 
Number of Loans
 
Facility Type
 
Principal Balance as of June 30, 2017
 
Book Value as of June 30, 2017
 
Weighted Average Contractual Interest Rate
 
Weighted Average Annualized Effective Interest Rate
 
Interest Income Three Months Ended June 30, 2017 (1)
 
Maturity Date
Mortgage
 
4

 
Skilled Nursing / Senior Housing
 
$
38,336

 
$
38,361

 
9.1
%
 
8.9
%
 
$
215

 
11/07/16- 04/30/18
Construction
 
2

 
Senior Housing
 
1,736

 
1,798

 
8.0
%
 
7.7
%
 
32

 
03/31/21- 05/31/22
Mezzanine
 
1

 
Senior Housing
 
9,640

 
9,646

 
11.0
%
 
10.8
%
 
268

 
08/31/17
Pre-development
 
1

 
Senior Housing
 
2,304

 
2,306

 
9.0
%
 
8.4
%
 
52

 
09/09/17
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
8

 
 
 
$
52,016

 
$
52,111

 
9.4
%
 
9.3
%
 
$
567

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Loan loss reserve
 
 
 
 
 

 
(3,248
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
$
52,016

 
$
48,863

 
 
 
 
 
 
 
 


Other Investment Type
 
Number of Investments
 
Facility Type
 
Total Funding Commitments
 
Amount Funded
 as of
June 30, 2017

 
Book Value
as of
June 30, 2017

 
Rate of Return
 
Other Income
Three Months Ended
June 30, 2017

Preferred Equity
 
12
 
Skilled Nursing / Senior Housing
 
$
36,706

 
$
36,706

 
$
45,345

 
12.9
%
 
$
1,428































(1) Includes interest income related to loans receivable investments held as of June 30, 2017.
SABRA HEALTH CARE REIT, INC.
PORTFOLIO SUMMARY (CONTINUED)
June 30, 2017
(dollars in thousands)

Proprietary Development Pipeline (1) 
 
 
Investment Type
 
Facility Type
 
Investment Amount (2)
 
Estimated Real Estate Value Upon Completion
 
Weighted Average Initial Cash Lease Yield
 
Certificate of Occupancy Timing(3)
State
 
Loan
 
Preferred Equity
 
Forward Commitment
 
Skilled Nursing/ Transitional Care
 
Senior Housing
 
Skilled Nursing/ Transitional Care
 
Senior Housing
 
Skilled Nursing/ Transitional Care
 
Senior Housing
 
 
Colorado
 
1

 
1

 

 

 
2

 
$

 
$
7,252

 
$

 
$
54,000

 
7.8
%
 
Q3 2016- Q4 2017
Florida
 

 

 
1

 

 
1

 

 

 

 
24,365

 
7.5
%
 
Q4 2017
Indiana
 

 
4

 

 

 
4

 

 
15,099

 

 
116,800

 
7.3
%
 
Q1 2017- Q4 2017
Kentucky
 

 
1

 

 

 
1

 

 
5,434

 

 
27,000

 
7.4
%
 
Q4 2015
Ohio
 
1

 
1

 

 

 
2

 

 
4,957

 

 
59,100

 
7.4
%
 
Q4 2016- Q1 2018
Tennessee
 

 
1

 

 

 
1

 

 
4,050

 

 
17,800

 
8.3
%
 
Q2 2017
Texas
 
2

 
4

 

 
1

 
5

 
4,421

 
13,206

 
18,100

 
65,900

 
8.0
%
 
Q4 2015- Q3 2018
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4

 
12

 
1

 
1

 
16

 
$
4,421

 
$
49,998

 
$
18,100

 
$
364,965

 
7.6
%
 
 



New Assets in Real Estate Portfolio (4) 
 
 
Facility Type
 
Beds/Units
 
Gross Book Value
 
% of Total Real Estate Invested
State
 
Skilled Nursing/Transitional Care
 
Senior Housing
 
Skilled Nursing/Transitional Care
 
Senior Housing
 
 
Arizona
 

 
1

 

 
48

 
$
10,212

 
0.4
%
Colorado
 

 
1

 

 
48

 
10,700

 
0.5
%
Illinois
 

 
1

 

 
53

 
5,571

 
0.2
%
Indiana
 

 
1

 

 
172

 
26,587

 
1.1
%
Nevada
 

 
1

 

 
68

 
23,670

 
1.0
%
Texas
 
1

 
4

 
125

 
195

 
55,802

 
2.4
%
Virginia
 

 
1

 

 
68

 
23,000

 
1.0
%
Wisconsin
 

 
1

 

 
60

 
10,099

 
0.4
%
Canada
 

 
1

 

 
74

 
26,961

 
1.2
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1

 
12

 
125

 
786

 
$
192,602

 
8.2
%










(1) Includes projects invested in or committed to as of June 30, 2017.
(2) Investment amount excludes accrued and unpaid interest receivable.
(3) Certificate of occupancy timing represents the period in which the certificate of occupancy has been received for a development project where construction has been completed
or when the certificate of occupancy is expected to be received for a development project that is currently under construction.
(4) Includes properties built since 2010 and included in real estate investments as of June 30, 2017.

sabralogo08.jpg
See reporting definitions.
10





SABRA HEALTH CARE REIT, INC.
YEAR TO DATE INVESTMENT ACTIVITY
For the Six Months Ended June 30, 2017
(dollars in thousands)
 
Initial Investment Date
 
Facility Type
 
Number of Properties
 
Beds/Units
 
2017 Amounts Invested (1)
 
Rate of Return/Initial Cash Yield
Real Estate Investments
 
 
 
 
 
 
 
 
 
 
 
Poet's Walk of Cedar Park
06/01/17
 
Senior Housing
 
1

 
68

 
$
14,456

 
7.50
%
Additions to Real Estate
Various
 
Multiple
 
N/A

 
N/A

 
1,110

 
8.07
%
Total Real Estate Investments
 
 
 
 
 
 
 
 
15,566

 
7.54
%
Loans Receivable
 
 
 
 
 
 
 
 
 
 
 
McKinney Construction Loan
03/14/16
 
Senior Housing
 
1

 
27

 
893

 
8.00
%
All Investments
 
 
 
 
 
 
 
 
$
16,459

 
7.57
%




















































(1) Real estate investments include capitalized acquisition costs.

sabralogo08.jpg
See reporting definitions.
11





SABRA HEALTH CARE REIT, INC.
PORTFOLIO CONCENTRATIONS (1) 

Relationship Concentration
q216relationship.jpg q22017relation.jpg
              

                      
Asset Class Concentration
                      
a63016relationship.jpg q22017assetclas.jpg

Payor Source Concentration (2)  
 
 
q22016payorsource.jpg q22017payoursource.jpg


 
(1) Concentrations are calculated using Annualized Revenue for real estate investments, investments in loans receivable and other investments while annualized Net Operating
Income is used for investments in Managed Properties.
(2) Tenant and borrower revenue presented one quarter in arrears.

sabralogo08.jpg
See reporting definitions.
12






SABRA HEALTH CARE REIT, INC.
REAL ESTATE PORTFOLIO GEOGRAPHIC CONCENTRATIONS
June 30, 2017
 
Property Type   
Location
 
Skilled Nursing/Transitional Care
 
Senior Housing
 
Managed Properties
  
Acute Care Hospital
  
Total
 
% of Total
Texas
 
4

 
13

 

 
1

 
18

 
9.8
%
New Hampshire
 
10

 
6

 

 

 
16

 
8.7

Kentucky
 
13

 
1

 

 

 
14

 
7.7

Connecticut
 
9

 
2

 

 

 
11

 
6.0

Canada
 

 

 
10

 

 
10

 
5.5

Florida
 
5

 
5

 

 

 
10

 
5.5

Michigan
 

 
10

 

 

 
10

 
5.5

Ohio
 
8

 

 

 

 
8

 
4.4

Oklahoma
 
6

 
1

 

 

 
7

 
3.8

Maryland
 
5

 
1

 

 

 
6

 
3.3

Other (28 states)
 
36

 
36

 
1

 

 
73

 
39.8

 
 
 
 
 
 
 
 
 
 
 
 
 
Total
 
96

 
75

 
11

 
1

 
183

 
100.0
%
 
 
 
 
 
 
 
 
 
 
 
 
 
% of Total properties
 
52.5
%
 
41.0
%
 
6.0
%
 
0.5
%
 
100.0
%
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Distribution of Beds/Units
 
 
Total Number of
Properties
 
Facility Type
 
 
 
 
Location
 
 
Skilled Nursing/Transitional Care
 
Senior Housing
 
Managed Properties
  
Acute Care Hospital
 
Total
 
% of Total
Texas
 
18

 
485

 
1,220

 

 
70

 
1,775

 
9.4
%
New Hampshire
 
16

 
904

 
838

 

 

 
1,742

 
9.3

Connecticut
 
11

 
1,350

 
140

 

 

 
1,490

 
7.9

Florida
 
10

 
660

 
617

 

 

 
1,277

 
6.8

Kentucky
 
14

 
1,044

 
68

 

 

 
1,112

 
5.9

Canada
 
10

 

 

 
941

 

 
941

 
5.0

Ohio
 
8

 
900

 

 

 

 
900

 
4.8

Maryland
 
6

 
782

 
68

 

 

 
850

 
4.5

Nebraska
 
6

 
400

 
296

 

 

 
696

 
3.7

Colorado
 
5

 
509

 
132

 

 

 
641

 
3.4

Other (28 states)
 
79

 
3,655

 
3,691

 
60

 

 
7,406

 
39.3

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total
 
183

 
10,689

 
7,070

 
1,001

 
70

 
18,830

 
100.0
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
% of Total beds/units
 
 
 
56.8
%
 
37.5
%
 
5.3
%
 
0.4
%
 
100.0
%
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 









sabralogo08.jpg
See reporting definitions.
13





SABRA HEALTH CARE REIT, INC.
REAL ESTATE PORTFOLIO GEOGRAPHIC CONCENTRATIONS
June 30, 2017
(dollars in thousands)

Investment
Location
 
Total Number of Properties
 
Skilled Nursing/Transitional Care
 
Senior Housing
 
Managed Properties
  
Acute Care Hospital
  
Total
 
% of Total
Texas
 
18

 
$
54,549

 
$
215,435

 
$

 
$
61,640

 
$
331,624

 
14.4
%
Maryland
 
6

 
278,569

 
6,566

 

 

 
285,135

 
12.3

Canada (1)
 
10

 

 

 
154,957

 

 
154,957

 
6.7

Connecticut
 
11

 
115,833

 
29,124

 

 

 
144,957

 
6.3

Florida
 
10

 
29,418

 
92,843

 

 

 
122,261

 
5.3

Delaware
 
4

 
95,780

 

 

 

 
95,780

 
4.1

Nebraska
 
6

 
63,088

 
28,297

 

 

 
91,385

 
4.0

New Hampshire
 
16

 
46,839

 
40,898

 

 

 
87,737

 
3.8

North Carolina
 
3

 
9,318

 
67,272

 

 

 
76,590

 
3.3

Michigan
 
10

 

 
74,413

 

 

 
74,413

 
3.2

Other (28 states)
 
89

 
345,564

 
489,816

 
9,377

 

 
844,757

 
36.6

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total
 
183

 
$
1,038,958

 
$
1,044,664

 
$
164,334

 
$
61,640

 
$
2,309,596

 
100.0
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
% of Total Properties
 
 
 
45.0
%
 
45.2
%
 
7.1
%
 
2.7
%
 
100.0
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 





































(1) Investment balance in Canada is based on the exchange rate as of June 30, 2017 of $0.7703 per CAD $1.00.

sabralogo08.jpg
See reporting definitions.
14




SABRA HEALTH CARE REIT, INC.
PORTFOLIO LEASE EXPIRATIONS (1)  
June 30, 2017
(dollars in thousands)
 

 
2020
 
2021
 
2022
 
2023
 
2024
 
2025
 
2026
 
Thereafter
 
Total
Skilled Nursing/Transitional Care
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Properties
9

 
8

 
26

 
13

 
19

 
2

 
4

 
15

 
96

Beds/Units
963

 
1,041

 
2,457

 
1,605

 
2,047

 
222

 
500

 
1,854

 
10,689

Annualized Revenues
$
6,275

 
$
7,213

 
$
34,462

 
$
12,860

 
$
22,310

 
$
2,007

 
$
10,578

 
$
42,611

 
$
138,316

Senior Housing
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Properties

 
2

 
13

 
2

 
9

 
13

 
1

 
33

 
73

Beds/Units

 
163

 
912

 
215

 
667

 
932

 
100

 
3,949

 
6,938

Annualized Revenues

 
1,070

 
9,285

 
1,487

 
7,087

 
10,442

 
628

 
53,819

 
83,818

Acute Care Hospital
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Properties

 

 

 

 

 

 

 
1

 
1

Beds/Units

 

 

 

 

 

 

 
70

 
70

Annualized Revenues

 

 

 

 

 

 

 
5,501

 
5,501

 
 
 
 

 
 

 
 

 
 

 
 

 
 

 
 
 
 

Total Properties
9

 
10

 
39

 
15

 
28

 
15

 
5

 
49

 
170

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total Beds/Units
963

 
1,204

 
3,369

 
1,820

 
2,714

 
1,154

 
600

 
5,873

 
17,697

 
 
 
 

 
 

 
 

 
 

 
 

 
 

 
 
 
 

Total Annualized Revenues
$
6,275

 
$
8,283

 
$
43,747

 
$
14,347

 
$
29,397

 
$
12,449

 
$
11,206

 
$
101,931

 
$
227,635

 
 
 
 

 
 

 
 

 
 

 
 

 
 

 
 
 
 

% of Revenue
2.8
%
 
3.6
%
 
19.2
%
 
6.3
%
 
12.9
%
 
5.5
%
 
4.9
%
 
44.8
%
 
100.0
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 


 



















(1) Excludes Managed Properties and two Senior Housing facilities transitioned to new operators that are not subject to leases.

sabralogo08.jpg
See reporting definitions.
15




SABRA HEALTH CARE REIT, INC.
RECENT INVESTMENT ACTIVITY
Poet's Walk of Cedar Park

cedarpark.jpg


•Investment Date:
 
June 1, 2017
 
 
 
•Investment Amount:
 
$14.5 million
 
 
 
•Investment Type:
 
Real Estate
 
 
 
•Number of Properties:
 
1
 
 
 
•Location:
 
Cedar Park, TX
 
 
 
•Available Beds/Units:
 
68
 
 
 
•Property Type:
 
Senior Housing
 
 
 
•Annualized GAAP Income:
 
$1.3 million
 
 
 
•Initial Cash Yield:
 
7.5%
 
 
 

















sabralogo08.jpg
See reporting definitions.
16




SABRA HEALTH CARE REIT, INC.
RECONCILIATIONS OF FFO, NORMALIZED FFO, AFFO AND NORMALIZED AFFO
(dollars in thousands, except per share data) 
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2017
 
2016
 
2017
 
2016
 
 
 
 
 
 
 
 
Net income attributable to common stockholders
$
17,960

 
$
34,915

 
$
34,222

 
$
16,643

Add:
 
 
 
 
 
 
 
Depreciation of real estate assets
17,220

 
16,405

 
36,357

 
34,171

Net (gain) loss on sales of real estate
(4,032
)
 
52

 
(4,032
)
 
4,654

Impairment of real estate

 

 

 
29,811

FFO attributable to common stockholders
$
31,148

 
$
51,372

 
$
66,547

 
$
85,279

 
 
 
 
 
 
 
 
Additional default interest income

 
(8,850
)
 

 
(4,212
)
Lease termination fee
(916
)
 
(2,098
)
 
(2,283
)
 
(2,098
)
CCP merger costs
5,876

 

 
6,407

 

Loss on extinguishment of debt

 

 

 
556

Provision for doubtful accounts and loan losses, net (1)
258

 
(409
)
 
1,985

 
1,860

Other normalizing items (2)
41

 
(252
)
 
112

 
(252
)
Normalized FFO attributable to common stockholders
$
36,407

 
$
39,763

 
$
72,768

 
$
81,133

 
 
 
 
 
 
 
 
FFO
$
31,148

 
$
51,372

 
$
66,547

 
$
85,279

Expensed acquisition pursuit costs (3)
5,888

 
82

 
6,451

 
171

Stock-based compensation expense
1,731

 
1,834

 
4,319

 
3,652

Straight-line rental income adjustments
(4,971
)
 
(5,524
)
 
(9,578
)
 
(11,117
)
Amortization of deferred financing costs
1,281

 
1,273

 
2,558

 
2,494

Non-cash portion of loss on extinguishment of debt

 

 

 
556

Change in fair value of contingent consideration

 
(50
)
 
(822
)
 
(50
)
Provision for doubtful straight-line rental income, loan losses and other reserves
534

 
92

 
1,924

 
2,615

Other non-cash adjustments (4)
523

 
344

 
922

 
648

AFFO attributable to common stockholders
$
36,134

 
$
49,423

 
$
72,321

 
$
84,248

Additional default interest income

 
(8,850
)
 

 
(4,212
)
Lease termination fee
(916
)
 
(2,098
)
 
(2,283
)
 
(2,098
)
Provision for doubtful cash income (1)

 
131

 
381

 

Other normalizing items (2)
26

 
(252
)
 
38

 
(252
)
Normalized AFFO attributable to common stockholders
$
35,244

 
$
38,354

 
$
70,457

 
$
77,686

Amounts per diluted common share attributable to common stockholders:
 
 
 
 
 
 
 
Net income
$
0.27

 
$
0.53

 
$
0.52

 
$
0.25

FFO
$
0.47

 
$
0.78

 
$
1.01

 
$
1.30

Normalized FFO
$
0.55

 
$
0.61

 
$
1.11

 
$
1.24

AFFO
$
0.55

 
$
0.75

 
$
1.10

 
$
1.28

Normalized AFFO
$
0.53

 
$
0.58

 
$
1.07

 
$
1.18

Weighted average number of common shares outstanding, diluted:
 
 
 
 
 
 
 
Net income, FFO and Normalized FFO
65,670,853

 
65,503,383

 
65,694,019

 
65,454,337

AFFO and Normalized AFFO
65,985,940

 
65,784,776

 
66,009,102

 
65,783,312

(1) See Reporting Definitions for definition of Normalized FFO and Normalized AFFO for further information.
(2) Other normalizing items for FFO includes non-Managed Properties operating expenses and ineffectiveness loss related to our LIBOR interest rate swaps. Other normalizing items for AFFO includes non-Managed Properties operating expenses.
(3) On October 1, 2016 we early adopted Accounting Standards Update 2017-01, Business Combinations (Topic 805), which clarifies the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as business acquisitions. All real estate acquisitions completed subsequent to October 1, 2016 were considered asset acquisitions and we have capitalized acquisition pursuit costs associated with these acquisitions, including those incurred prior to October 1, 2016. Acquisitions completed prior to October 1, 2016 were deemed business combinations and the related acquisition pursuit costs were expensed as incurred. Acquisition costs incurred during the three and six months ended June 30, 2017 primarily relate to the pending Merger transaction.
(4) Other non-cash adjustments include amortization of debt premiums/discounts, non-cash interest income adjustments and amortization expense related to our interest rate hedges.

sabralogo08.jpg
See reporting definitions.
17




SABRA HEALTH CARE REIT, INC.
RECONCILIATIONS OF NOI AND SAME STORE CASH NOI
(dollars in thousands)

Three Months Ended June 30,
2017
 
2016
 
Skilled Nursing/ Transitional Care
 
Senior Housing
 
Managed Properties
 
Acute Care Hospital
 
Other
 
Total
 
Skilled Nursing/ Transitional Care
 
Senior Housing
 
Managed Properties
 
Acute Care Hospital
 
Other
 
Total
Net income (loss)
$
29,477

 
$
12,063

 
$
1,259

 
$
901

 
$
(23,164
)
 
$
20,536

 
$
24,832

 
$
11,781

 
$
241

 
$
844

 
$
(232
)
 
$
37,466

Adjustments:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Depreciation and amortization
7,994

 
7,396

 
1,139

 
475

 
216

 
17,220

 
7,961

 
7,488

 
278

 
477

 
201

 
16,405

Interest
1,159

 
471

 

 

 
14,232

 
15,862

 
1,363

 
499

 

 

 
14,565

 
16,427

General and administrative

 

 

 

 
11,149

 
11,149

 

 

 

 

 
4,636

 
4,636

Provision for doubtful accounts and loan losses

 

 

 

 
535

 
535

 

 

 

 

 
223

 
223

Impairment of real estate

 

 

 

 

 

 

 

 

 

 

 

Loss on extinguishment of debt

 

 

 

 

 

 

 

 

 

 

 

Other income

 

 

 

 
(941
)
 
(941
)
 

 

 

 

 
(2,400
)
 
(2,400
)
Net (gain) loss on sale of real estate
(4,032
)
 

 

 

 

 
(4,032
)
 

 

 

 
52

 

 
52

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total net operating income
$
34,598

 
$
19,930

 
$
2,398

 
$
1,376

 
$
2,027

 
$
60,329

 
$
34,156

 
$
19,768

 
$
519

 
$
1,373

 
$
16,993

 
$
72,809

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net operating income not included in same-store
(1,308
)
 
(2,439
)
 
(1,835
)
 

 
 
 
 
 
(1,630
)
 
(1,445
)
 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total same store net operating income (1)
$
33,290

 
$
17,491

 
$
563

 
$
1,376

 
 
 
 
 
$
32,526

 
$
18,323

 
$
519

 
$
1,373

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Straight-line rental income adjustments
(2,141
)
 
(2,060
)
 

 
(95
)
 
 
 
 
 
(2,288
)
 
(2,743
)
 

 
(117
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Same store cash net operating income (1)
$
31,149

 
$
15,431

 
$
563

 
$
1,281

 
 
 
 
 
$
30,238

 
$
15,580

 
$
519

 
$
1,256

 
 
 
 












(1) Same store includes all real estate facilities owned for the full period in both comparison periods.


sabralogo08.jpg
See reporting definitions.
18




SABRA HEALTH CARE REIT, INC.
RECONCILIATIONS OF NOI AND SAME STORE CASH NOI (CONTINUED)
(dollars in thousands)


Six Months Ended June 30,
2017
 
2016
 
Skilled Nursing/ Transitional Care
 
Senior Housing
 
Managed Properties
 
Acute Care Hospital
 
Other
 
Total
 
Skilled Nursing/ Transitional Care
 
Senior Housing
 
Managed Properties
 
Acute Care Hospital
 
Other
 
Total
Net income (loss)
$
54,543

 
$
23,308

 
$
1,769

 
$
1,799

 
$
(42,092
)
 
$
39,327

 
$
54,481

 
$
23,482

 
$
480

 
$
(29,811
)
 
$
(26,909
)
 
$
21,723

Adjustments:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Depreciation and amortization
16,038

 
17,245

 
1,690

 
952

 
432

 
36,357

 
15,940

 
14,938

 
542

 
2,367

 
384

 
34,171

Interest
2,328

 
953

 

 

 
28,369

 
31,650

 
2,736

 
992

 

 

 
29,617

 
33,345

General and administrative

 

 

 

 
18,022

 
18,022

 

 

 

 

 
9,350

 
9,350

Provision for doubtful accounts and loan losses

 

 

 

 
2,305

 
2,305

 

 

 

 

 
2,746

 
2,746

Impairment of real estate

 

 

 

 

 

 

 

 

 
29,811

 

 
29,811

Loss on extinguishment of debt

 

 

 

 

 

 

 

 

 

 
556

 
556

Other income

 

 

 

 
(3,070
)
 
(3,070
)
 

 

 

 

 
(2,400
)
 
(2,400
)
Net (gain) loss on sale of real estate
(4,026
)
 
(6
)
 

 

 

 
(4,032
)
 
4,602

 

 

 
52

 

 
4,654

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total net operating income
$
68,883

 
$
41,500

 
$
3,459

 
$
2,751

 
$
3,966

 
$
120,559

 
$
77,759

 
$
39,412

 
$
1,022

 
$
2,419

 
$
13,344

 
$
133,956

























sabralogo08.jpg
See reporting definitions.
19



SABRA HEALTH CARE REIT, INC.
REPORTING DEFINITIONS

Acute Care Hospital. A facility designed to provide extended medical and rehabilitation care for patients who are clinically complex and have multiple acute or chronic conditions.
Annualized Revenues. The annual straight-line rental revenues under leases and interest and other income generated by the Company's loans receivable and other investments based on amounts invested and applicable terms as of the end of the period presented. Annualized Revenues do not include tenant recoveries or additional rents.  The Company uses Annualized Revenues for the purpose of determining revenue concentrations and lease expirations.
Cash Net Operating Income (“Cash NOI”).   The Company believes that net income attributable to common stockholders as defined by GAAP is the most appropriate earnings measure. We consider Cash NOI an important supplemental measure because it allows investors, analysts and our management to evaluate the operating performance of our investments. We define Cash NOI as total revenues less operating expenses and non-cash revenues. Cash NOI excludes all other financial statement amounts included in net income.
EBITDAR. Earnings before interest, taxes, depreciation, amortization and rent (“EBITDAR”) for a particular facility accruing to the operator/tenant of the property (not the Company) for the period presented. The Company uses EBITDAR in determining EBITDAR Coverage. EBITDAR has limitations as an analytical tool. EBITDAR does not reflect historical cash expenditures or future cash requirements for facility capital expenditures or contractual commitments. In addition, EBITDAR does not represent a property's net income or cash flow from operations and should not be considered an alternative to those indicators. The Company utilizes EBITDAR as a supplemental measure of the ability of the Company's operators/tenants and relevant guarantors to generate sufficient liquidity to meet related obligations to the Company.
EBITDAR Coverage. Represents the ratio of EBITDAR to contractual rent for owned facilities (excluding Managed Properties). EBITDAR Coverage is a supplemental measure of an operator/tenant's ability to meet their cash rent and other obligations to the Company. However, its usefulness is limited by, among other things, the same factors that limit the usefulness of EBITDAR.
EBITDARM. Earnings before interest, taxes, depreciation, amortization, rent and management fees (“EBITDARM”) for a particular facility accruing to the operator/tenant of the property (not the Company), for the period presented. The Company uses EBITDARM in determining EBITDARM Coverage. The usefulness of EBITDARM is limited by the same factors that limit the usefulness of EBITDAR. Together with EBITDAR, the Company utilizes EBITDARM to evaluate the core operations of the properties by eliminating management fees, which vary based on operator/tenant and its operating structure.
EBITDARM Coverage. Represents the ratio of EBITDARM to contractual rent for owned facilities (excluding Managed Properties). EBITDARM coverage is a supplemental measure of a property's ability to generate cash flows for the operator/tenant (not the Company) to meet the operator's/tenant's related cash rent and other obligations to the Company. However, its usefulness is limited by, among other things, the same factors that limit the usefulness of EBITDARM.
Enterprise Value. The Company believes Enterprise Value is an important measurement as it is a measure of a company’s value. We calculate Enterprise Value as market equity capitalization plus debt. Market equity capitalization is calculated as the number of shares of common stock multiplied by the closing price of our common stock on the last day of the period presented. Total Enterprise Value includes our market equity capitalization and consolidated debt, less cash and cash equivalents.
Fixed Charge Coverage Ratio. EBITDAR (including adjustments for one-time and pro forma items) for the period indicated (one quarter in arrears) for all operations of any entities that guarantee the tenants' lease obligations to the Company divided by the same period cash rent expense, interest expense and mandatory principal payments for operations of any entity that guarantees the tenants' lease obligation to the Company. Fixed Charge Coverage is a supplemental measure of a guarantor's ability to meet the operator/tenant's cash rent and other obligations to the Company should the operator/tenant be unable to do so itself. However, its usefulness is limited by, among other things, the same factors that limit the usefulness of EBITDAR. Fixed Charge Coverage is calculated by the Company as described above based on information provided by guarantors without independent verification by the Company and may differ from similar metrics calculated by the guarantors.
Funds From Operations Attributable to Common Stockholders (“FFO”) and Adjusted Funds from Operations Attributable to Common Stockholders (“AFFO”). The Company believes that net income attributable to common stockholders as defined by GAAP is the most appropriate earnings measure. The Company also believes that Funds From Operations, or FFO, as defined in accordance with the definition used by the National Association of Real Estate Investment Trusts (“NAREIT”), and Adjusted Funds from Operations, or AFFO (and related per share amounts) are important non-GAAP supplemental measures of the Company's operating performance. Because the historical cost accounting convention used for real estate assets requires straight-line depreciation (except on land), such accounting presentation implies that the value of real estate assets diminishes predictably over time. However, since real estate values have historically risen or fallen with market and other conditions, presentations of operating results for a real estate investment trust that uses historical cost accounting for depreciation could be less informative. Thus, NAREIT created FFO as a supplemental measure of operating performance for real estate investment trusts that excludes historical cost depreciation and amortization, among other items, from net income attributable to common stockholders, as defined by GAAP. FFO is defined as net income attributable to common stockholders, computed in accordance with GAAP, excluding gains or losses from real estate dispositions, plus real estate depreciation and amortization and real estate impairment charges. AFFO is defined as FFO excluding straight-line rental income adjustments, stock-based compensation expense, amortization of deferred financing costs, acquisition pursuit costs, as well as other non-cash revenue and expense items (including provisions and write-offs related to

sabralogo33117.jpg
 
20

SABRA HEALTH CARE REIT, INC.
REPORTING DEFINITIONS

straight-line rental income, provision for loan losses, changes in fair value of contingent consideration, amortization of debt premiums/discounts and non-cash interest income adjustments). The Company believes that the use of FFO and AFFO (and the related per share amounts), combined with the required GAAP presentations, improves the understanding of the Company's operating results among investors and makes comparisons of operating results among real estate investment trusts more meaningful. The Company considers FFO and AFFO to be useful measures for reviewing comparative operating and financial performance because, by excluding the applicable items listed above, FFO and AFFO can help investors compare the operating performance of the Company between periods or as compared to other companies. While FFO and AFFO are relevant and widely used measures of operating performance of real estate investment trusts, they do not represent cash flows from operations or net income attributable to common stockholders as defined by GAAP and should not be considered an alternative to those measures in evaluating the Company’s liquidity or operating performance. FFO and AFFO also do not consider the costs associated with capital expenditures related to the Company’s real estate assets nor do they purport to be indicative of cash available to fund the Company’s future cash requirements. Further, the Company’s computation of FFO and AFFO may not be comparable to FFO and AFFO reported by other real estate investment trusts that do not define FFO in accordance with the current NAREIT definition or that interpret the current NAREIT definition or define AFFO differently than the Company does.
Investment. Represents the carrying amount of real estate assets after adding back accumulated depreciation and amortization.
Market Capitalization. Total common shares of Sabra outstanding multiplied by the closing price per common share as of a given period.
Net Operating Income (“NOI”).  The Company believes that net income attributable to common stockholders as defined by GAAP is the most appropriate earnings measure. We consider NOI an important supplemental measure because it allows investors, analysts and our management to evaluate the operating performance of our investments. We define NOI as total revenues less operating expenses. NOI excludes all other financial statement amounts included in net income.

Normalized FFO and Normalized AFFO. Normalized FFO and Normalized AFFO represent FFO and AFFO, respectively, adjusted for certain income and expense items that the Company does not believe are indicative of its ongoing operating results. The Company considers Normalized FFO and Normalized AFFO to be useful measures to evaluate the Company’s operating results excluding these income and expense items to help investors compare the operating performance of the Company between periods or as compared to other companies. Normalized FFO and Normalized AFFO do not represent cash flows from operations or net income as defined by GAAP and should not be considered an alternative to those measures in evaluating the Company’s liquidity or operating performance. Normalized FFO and Normalized AFFO also do not consider the costs associated with capital expenditures related to the Company’s real estate assets nor do they purport to be indicative of cash available to fund the Company’s future cash requirements. Further, the Company’s computation of Normalized FFO and Normalized AFFO may not be comparable to Normalized FFO and Normalized AFFO reported by other REITs that do not define FFO in accordance with the current NAREIT definition or that interpret the current NAREIT definition or define FFO and AFFO or Normalized FFO and Normalized AFFO differently than the Company does.
Occupancy Percentage. Occupancy Percentage represents the facilities’ average operating occupancy for the period indicated. The percentages are calculated by dividing the actual census from the period presented by the available beds/units for the same period. Occupancy for independent living facilities can be greater than 100% for a given period as multiple residents could occupy a single unit.
Senior Housing. Senior housing facilities include independent living, assisted living, continuing care retirement community and memory care facilities.
Skilled Mix. Skilled Mix is defined as the total Medicare and non-Medicaid managed care patient revenue at Skilled Nursing/Transitional Care facilities divided by the total revenues at Skilled Nursing/Transitional Care facilities for the period indicated.
Skilled Nursing/Transitional Care. Skilled nursing/transitional care facilities include skilled nursing, transitional care, multi-license designation and mental health facilities.
Stabilized Facility. At the time of acquisition, the Company classifies each facility as either stabilized or pre-stabilized. In addition, the Company may classify a facility as pre-stabilized after acquisition. Circumstances that could result in a facility being classified as pre-stabilized include newly completed developments, facilities undergoing major renovations or additions, facilities being repositioned or transitioned to new operators, and significant transitions within the tenants’ business model. Such facilities will be reclassified to stabilized upon maintaining consistent occupancy (85% for Skilled Nursing/Transitional Care and 90% for Senior Housing Facilities) but in no event beyond 24 months after the date of classification as pre-stabilized. Stabilized Facilities exclude (i) Managed Properties, (ii) facilities held for sale, (iii) facilities being positioned to be sold, (iv) facilities being transitioned from leased by the Company to being operated by the Company, and (v) facilities acquired during the three months preceding the period presented.
Total Debt. The carrying amount of the Company’s revolving credit facility, term loan, senior unsecured notes, and mortgage indebtedness, as reported in the Company’s condensed consolidated financial statements.


sabralogo33117.jpg
 
21